A
0.231
0.00 (-0.43%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | AEON Biopharma, Inc. | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.9 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 0.0 |
| 相对估值 | NA |
| 财务健康 | -3.5 |
| 宏观环境 | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | -0.03 |
|
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 24.46% |
| 机构持股比例 | 14.66% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Beacon Wealthcare Llc | 30 Sep 2026 | 12,856 |
该时间范围内无数据。
该时间范围内无数据。
投资组合